Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

SELL
$160.42 - $256.21 $4,973 - $7,942
-31 Reduced 25.62%
90 $17,000
Q2 2022

Jul 28, 2022

BUY
$140.68 - $188.02 $2,813 - $3,760
20 Added 19.8%
121 $20,000
Q1 2022

May 06, 2022

SELL
$161.19 - $257.96 $11,605 - $18,573
-72 Reduced 41.62%
101 $19,000
Q4 2021

Feb 10, 2022

BUY
$247.59 - $304.47 $42,833 - $52,673
173 New
173 $46,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.77B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Sageworth Trust CO Of South Dakota Portfolio

Follow Sageworth Trust CO Of South Dakota and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sageworth Trust CO Of South Dakota, based on Form 13F filings with the SEC.

News

Stay updated on Sageworth Trust CO Of South Dakota with notifications on news.